Resmed RSMDF

NYSE RSMDF
$24.52 +0.00 (+0.00%)
At close: Sep 7, 2026 · 4:00 PM EDT
Key Stats
Market Cap3.54 Bn
P/E2.34
P/S0.63
Div. Yield9.89
Total Debt (Qtr)919.32 Mn
Revenue Growth (1y) (Qtr)8.58
Add ratio to table…

About

ResMed Inc is a global leader in digital health and cloud-connected medical devices that designs innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. The company focuses on sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases, providing comprehensive residential care software platforms that support professionals and caregivers helping people stay healthy in the home or care…

Read more ↓
Sectors: Healthcare Technology Sector rationale The primary revenue driver is the design and sale of medical devices for sleep apnea and respiratory disorders, such as CPAP and bilevel systems, which falls under Medical Devices in Healthcare. A secondary sector of Technology is justified because the company operates a distinct 'Residential Care Software' segment providing cloud-based business management, EHR, and revenue cycle management tools sold as software solutions to healthcare providers. Industries: Medical Devices Medical Devices Primary ResMed designs and manufactures therapeutic medical devices for sleep apnea and respiratory disorders, specifically CPAP, APAP, bilevel, and high flow therapy systems. These are regulated treatment devices sold to patients, hospitals, and home medical equipment providers. Healthcare IT Healthcare IT Secondary The company provides a Residential Care Software segment that sells electronic health records, revenue cycle management, and workforce management tools specifically for residential care providers, embedding healthcare-specific workflows and reimbursement compliance. Dental Dental Secondary The company explicitly generates revenue from the sale of dental devices used in the treatment of sleep apnea and respiratory conditions. Classified using BQ-MICS CIK: 0000943819

Segments Breakdown of Revenue (2026)

Statement Business Segments Breakdown of Revenue (2026)

Peer group

Peer Comparison

Companies in the Medical Devices
S.No. Ticker Company matchMarket CapP/EP/STotal Debt (Qtr)
1 ABT Abbott Laboratories primary187.42 Bn34.754.0232.61 Bn
2 ISRG Intuitive Surgical Inc primary129.78 Bn41.1211.76-
3 MDT Medtronic plc primary120.53 Bn22.863.2128.15 Bn
4 BSX Boston Scientific Corp primary69.29 Bn19.133.3012.62 Bn
5 EW Edwards Lifesciences Corp primary51.83 Bn51.637.960.60 Bn
6 ALC Alcon Inc primary34.36 Bn54.083.194.15 Bn
7 DXCM Dexcom Inc primary33.17 Bn33.616.68-
8 STE STERIS plc primary21.90 Bn27.133.632.14 Bn